Literature DB >> 20663524

Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats.

Minoru Miyazato1, Kimio Sugaya, Seiichi Saito, Michael B Chancellor, William F Goins, James R Goss, William C de Groat, Joseph C Glorioso, Naoki Yoshimura.   

Abstract

PURPOSE: We investigated whether replication defective herpes simplex virus vectors encoding genes of glutamic acid decarboxylase, the gamma-aminobutyric acid synthesis enzyme, could suppress detrusor-sphincter dyssynergia in rats with spinal cord injury.
MATERIALS AND METHODS: One week after spinalization herpes simplex virus vectors expressing glutamic acid decarboxylase and green fluorescent protein were injected into the bladder wall. Spinal cord injured rats without herpes simplex virus injection (sham treated) and those injected with LacZ encoding herpes simplex virus vectors served as controls. Three weeks after viral injection we simultaneously recorded urethral and intravesical pressure in awake rats.
RESULTS: In the glutamic acid decarboxylase group the urethral pressure increase during bladder contraction was significantly decreased by 77% to 79% compared with that in the sham treated and LacZ groups. Bladder activity and urethral baseline pressure did not differ among the 3 groups. Intrathecal application of the gamma-aminobutyric acid-A receptor antagonist bicuculline almost completely reversed the decrease in the urethral pressure increase during bladder contractions while intrathecal saclofen (Tocris Cookson, Ellisville, Missouri), a gamma-aminobutyric acid-B receptor antagonist, partially reversed it. In the glutamic acid decarboxylase group the mRNA of glutamic acid decarboxylase 67 was significantly increased in L6-S1 dorsal root ganglia, which is where bladder afferents originate, compared with that in the LacZ group.
CONCLUSIONS: Herpes simplex virus based glutamic acid decarboxylase gene transfer to bladder afferent pathway may represent a novel approach to detrusor-sphincter dyssynergia in cases of spinal cord injury. 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663524      PMCID: PMC2921014          DOI: 10.1016/j.juro.2010.04.066

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology.

Authors:  W D Steers; J M Meythaler; C Haworth; D Herrell; T S Park
Journal:  J Urol       Date:  1992-12       Impact factor: 7.450

2.  Effects of glutamate receptor antagonists on lower urinary tract function in conscious unanesthetized rats.

Authors:  O Nishizawa; Y Igawa; T Satoh; S Yamashiro; K Sugaya
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

3.  Anatomical and physiological observations on supraspinal control of bladder and urethral sphincter muscles in the cat.

Authors:  G Holstege; D Griffiths; H de Wall; E Dalm
Journal:  J Comp Neurol       Date:  1986-08-22       Impact factor: 3.215

4.  Clinical and laboratory assessment of the efficacy of baclofen (Lioresal) on urethral sphincter spasticity in patients with traumatic paraplegia.

Authors:  H J Hachen; V Krucker
Journal:  Eur Urol       Date:  1977       Impact factor: 20.096

5.  Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.

Authors:  W F Goins; N Yoshimura; M W Phelan; T Yokoyama; M O Fraser; H Ozawa; J R Bennett N; W C de Groat; J C Glorioso; M B Chancellor
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

6.  Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats.

Authors:  Satoshi Seki; Katsumi Sasaki; Yasuhiko Igawa; Osamu Nishizawa; Michael B Chancellor; William C De Groat; Naoki Yoshimura
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

7.  Spinal and supraspinal components of GABAergic inhibition of the micturition reflex in rats.

Authors:  C A Maggi; M Furio; P Santicioli; B Conte; A Meli
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

8.  Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain.

Authors:  Jun Liu; Darren Wolfe; Shuanglin Hao; Shaohua Huang; Joseph C Glorioso; Marina Mata; David J Fink
Journal:  Mol Ther       Date:  2004-07       Impact factor: 11.454

9.  Roles of opiate in lower urinary tract dysfunction associated with spinal cord injury in rats.

Authors:  Osamu Yokoyama; Eiko Mita; Hironobu Akino; Kazuya Tanase; Hirokazu Ishida; Mikio Namiki
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

10.  Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord.

Authors:  Kimberly A Moore; Tatsuro Kohno; Laurie A Karchewski; Joachim Scholz; Hiroshi Baba; Clifford J Woolf
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  14 in total

Review 1.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

3.  Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury.

Authors:  Nobutaka Shimizu; Mark F Doyal; William F Goins; Katsumi Kadekawa; Naoki Wada; Anthony J Kanai; William C de Groat; Akihide Hirayama; Hirotsugu Uemura; Joseph C Glorioso; Naoki Yoshimura
Journal:  Neuroscience       Date:  2017-09-20       Impact factor: 3.590

4.  Comparison of GAD65 and 67 immunoreactivity in the lumbar spinal cord between young adult and aged dogs.

Authors:  Hyun Joo Lee; Jung Hoon Choi; Ji Hyeon Ahn; Choong Hyun Lee; Ki-Yeon Yoo; In Koo Hwang; Jin Sang Kim; Choonghyo Kim; Yun Lyul Lee; Hyung-Cheul Shin; Moo-Ho Won
Journal:  Neurochem Res       Date:  2010-12-31       Impact factor: 3.996

5.  Improvement in detrusor-sphincter dyssynergia by bladder-wall injection of replication-defective herpes simplex virus vector-mediated gene delivery of kynurenine aminotransferase II in spinal cord injury rats.

Authors:  Z Wang; L Liao
Journal:  Spinal Cord       Date:  2016-12-20       Impact factor: 2.772

Review 6.  Plasticity in reflex pathways to the lower urinary tract following spinal cord injury.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Exp Neurol       Date:  2011-05-09       Impact factor: 5.330

Review 7.  Early interventions to prevent lower urinary tract dysfunction after spinal cord injury: a systematic review.

Authors:  Nicolas Vamour; Pierre-Luc Dequirez; Denis Seguier; Patrick Vermersch; Stefan De Wachter; Xavier Biardeau
Journal:  Spinal Cord       Date:  2022-04-04       Impact factor: 2.772

8.  Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors.

Authors:  Seiji Kuroda; Yoshitaka Miyagawa; Makoto Sukegawa; Taro Tomono; Motoko Yamamoto; Kumi Adachi; Gianluca Verlengia; William F Goins; Justus B Cohen; Joseph C Glorioso; Takashi Okada
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-13       Impact factor: 5.849

9.  Effect of intravenous transplantation of bone marrow mesenchymal stem cells on neurotransmitters and synapsins in rats with spinal cord injury.

Authors:  Shaoqiang Chen; Bilian Wu; Jianhua Lin
Journal:  Neural Regen Res       Date:  2012-07-05       Impact factor: 5.135

Review 10.  Herpes simplex virus-based nerve targeting gene therapy in pain management.

Authors:  James R Goss; David Krisky; James Wechuck; Darren Wolfe
Journal:  J Pain Res       Date:  2014-01-20       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.